Filter
856
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
89
New Publications
197
Language
Document type
No document type
362
Studies & Reports
194
Guidelines
159
Manuals
63
Strategic & Response Plan
44
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
43
India
28
Kenya
27
Nigeria
23
Western and Central Europe
22
Ethiopia
19
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Tanzania
10
Eastern Europe
10
Ghana
9
Philippines
9
Rwanda
9
Namibia
9
Latin America and the Carribbean
9
Zimbabwe
8
Malawi
8
Nepal
7
Africa
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
88
Public Health
44
Key Resources
40
Pharmacy & Technologies
36
Women & Child Health
29
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
105
COVID-19
61
TB
45
HIV
44
Mental Health
32
Rapid Response
29
NTDs
28
NCDs
19
Global Health Education
18
Planetary Health
18
Conflict
15
Malaria
14
2.0 Rapid Response
14
Caregiver
12
Health Financing Toolbox
12
Specific Hazards
7
Disability
6
Ebola & Marburg
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
This document on logistics management information systems (LMIS) was developed to address the increasing need for harmonization and standardization of core indicators for managing medicines and health products for neglected tropical diseases (NTDs) at country level (i.e. for last-mile logistics). It
...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj
...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and
...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingui
...
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in
...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been
...
Access to controlled medicines. 3rd edition
Drug Advisory Board
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
First edition, November 1997 | Revised July 2002
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Health Evidence Network synthesis report 72
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
